Wells Fargo has presented the Federal Reserve with a satisfactory plan on how to unwind its business in case of bankruptcy. » Read More
By: CNBC.com staff
Alcoa Corp. on Monday reported first-quarter earnings per share of 63 cents, ex-items, compared to 53 cents per share, which analysts polled by Thomson Reuters had expected. » Read More
By: Michelle Fox
With U.S. stocks being so momentum-driven right now, investors need to make sure they look at the longer-term picture, Brian Belski said. » Read More
By: Chantel McGee
One tech analyst says he sees some issues with Amazon stock. » Read More
Trump is on pace for a nearly 5 percent gain in the S&P 500 since his inauguration. His 100 days ends on Saturday.
Arconic said it was willing to nominate two of activist hedge fund Elliott Management's director nominees to its board.
Trump has signed more than two dozen executive orders on issues ranging from border security to government restructuring and financial reform.
Trump's stance on trade is cause for "much" concern, Yoo Il-ho told CNBC on Monday.
Tied to your smartphone, TravelMate matches your speed and can navigate around large crowds without bumping into anyone.
Any vote on healthcare legislation would be determined by Republican leaders when they have enough votes, White House spokesman Sean Spicer said.
Amazon may be introducing new delivery options for furniture sellers, a trade publication said.
Happiness expert Gretchen Rubin can help you quit whining and get to business.
Manage your baby’s crying with the click of a button.
The days of dollar strength appear to be over for now, creating a boost for profits of global companies.
Samsung said on Monday that pre-orders for the Galaxy S8 beat out Galaxy S7 pre-orders by 30 percent.
In December, the Nasdaq topped 5,500 for the first time ever.
People line up around the block for this Android smartphone, and it costs half as much as other flagships.
All 100 senators have been asked to the White House for the briefing.
It targeted individuals within a Syrian agency that the department says is responsible for the development of chemical weapons.
German healthcare conglomerate Fresenius is close to acquiring generic drugmaker Akorn in an all-cash deal valuing the company at more than $4 billion
Get the best of CNBC in your inbox
CNBC contributor Mike Khouw breaks down the implied move on earnings in the airlines sector.
Chris Krueger, Cowen Washington Research Group strategist, weighs in on President Trump's tax agenda. The "Fast Money" traders weigh in.
CNBC's Courtney Reagan reports on the after-hours action for Whirlpool Corp.